Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of gastric cancer

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1578-1584

  Fan, Nai Jun ^a   Li, Ke ^a   Liu, Qing Yin ^a   Wang, Xiu Li ^a   Hu, Liang ^a   Li, Jun Tang ^a   Gao, Chun Fang ^a  

^a Institute of Anal Colorectal Surgery   (China)

Author keywords

Biological markers; Cytochrome b c1 complex subunit 1; Diagnosis; Proteomics; Stomach neoplasms; Thymosin beta 4 like protein 3; Tubulin beta chain

Indexed keywords

BETA TUBULIN; CYTOCHROME B; MEMBRANE PROTEIN; THYMOSIN BETA 4 LIKE PROTEIN 3; UNCLASSIFIED DRUG;

ADENOMA; ADULT; AGED; ARTICLE; BETA CHAIN; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER STAGING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ALGORITHM; HUMAN; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROLOGY; STOMACH CANCER; STOMACH CARCINOGENESIS;

BIOLOGICAL MARKERS; CYTOCHROME B-C(1) COMPLEX SUBUNIT 1; DIAGNOSIS; PROTEOMICS; STOMACH NEOPLASMS; THYMOSIN BETA-4-LIKE PROTEIN 3; TUBULIN BETA CHAIN;

ADENOMA; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; THYMOSIN; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84884350810     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.05.068     Document Type: Article

References (32)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Lin L.L., Huang H.C., Juan H.F. Discovery of biomarkers for gastric cancer: a proteomics approach. J Proteomics 2012, 75:3081-3097.
3. Ahlquist D.A. Molecular detection of colorectal neoplasia. Gastroenterology 2010, 138:2127-2139.
4. Ebert M.P., Rocken C. Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 2006, 18:847-853.
5. Wulfkuhle J.D., Liotta L.A., Petricoin E.F. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003, 3:267-275.
6. Issaq H.J., Xiao Z., Veenstra T.D. Serum and plasma proteomics. Chem Rev 2007, 107:3601-3620.
7. Pan C., He N., Zhao M., Gu Y., Huang Z., Li W., et al. Subdividing the m1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Med Oncol 2011, 28:1349-1355.
8. Fan N.J., Gao C.F., Zhao G., Wang X.L., Qiao L. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. Biotechnol Appl Biochem 2012, 59:276-282.
9. Fan N.J., Gao C.F., Zhao G., Wang X.L., Liu Q.Y. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol 2012, 7:45.
10. Fan N.J., Gao C.F., Wang X.L. Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterol Res Pract 2011, 2011:784967.
11. Tang W., Shi Y.Q., Zou J.J., Chen X.F., Zheng J.Y., Zhao S.W., et al. Serum biomarker of diabetic peripheral neuropathy indentified by differential proteomics. Front Biosci 2011, 16:2671-2681.
12. Ketterlinus R., Hsieh S.Y., Teng S.H., Lee H., Pusch W. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques 2005, 37-40. [Suppl.].
13. Fan N.J., Gao C.F., Wang X.L., Zhao G., Liu Q.Y., Zhang Y.Y., et al. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. J Biomed Biotechnol 2012, 2012:985020.
14. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
15. Yeh I.T., Luduena R.F. The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers. Cell Motil Cytoskeleton 2004, 57:96-106.
16. Bryan J., Wilson L. Are cytoplasmic microtubules heteropolymers?. Proc Natl Acad Sci U S A 1971, 68:1762-1766.
17. Perez E.A. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 2009, 8:2086-2095.
18. Dumontet C., Jordan M.A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010, 9:790-803.
19. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010, 10:194-204.
20. Zheng W.E., Chen H., Yuan S.F., Wu L.L., Zhang W., Sun H.Y., et al. Overexpression of betaIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. J BUON 2012, 17:284-290.
21. Bouras G., Nakanishi T., Fujita Y., Tsunemi S., Takubo T., Tanigawa N. Identification of beta-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection. Anal Bioanal Chem 2012, 403:1801-1809.
22. Xiao Y., Chen Y., Wen J., Yan W., Zhou K., Cai W. Thymosin beta4: a potential molecular target for tumor therapy. Crit Rev Eukaryot Gene Expr 2012, 22:109-116.
23. Ryu Y.K., Lee Y.S., Lee G.H., Song K.S., Kim Y.S., Moon E.Y. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration. Int J Cancer 2012, 131:2067-2077.
24. Kim N.S., Kang Y.J., Jo J.O., Kim H.Y., Oh Y.R., Kim Y.O., et al. Elevated expression of thymosin beta4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers. Pathol Oncol Res 2011, 17:493-502.
25. Nemolato S., Restivo A., Cabras T., Coni P., Zorcolo L., Orru G., et al. Thymosin beta 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition. Cancer Biol Ther 2012, 13:191-197.
26. Tang M.C., Su Y. Thymosin beta(4) knockdown disrupts mitochondrial functions of sw480 human colon cancer cells. Cancer Sci 2011, 102:1665-1672.
27. Yoon S.Y., Lee H.R., Park Y., Kim J.H., Kim S.Y., Yoon S.R., et al. Thymosin beta4 expression correlates with lymph node metastasis through hypoxia inducible factor-alpha induction in breast cancer. Oncol Rep 2011, 25:23-31.
28. Zhang Y., Feurino L.W., Zhai Q., Wang H., Fisher W.E., Chen C., et al. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 2008, 7:419-423.
29. 1 subunits between prokaryotes, mitochondria, and chloroplasts. J Bioenerg Biomembr 1988, 20:59-83.
30. Qasim M., Rahman H., Oellerich M., Asif A.R. Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment. Proteome Sci 2011, 9:57.
31. Arianmanesh M., McIntosh R.H., Lea R.G., Fowler P.A., Al-Gubory K.H. Ovine corpus luteum proteins, with functions including oxidative stress and lipid metabolism, show complex alterations during implantation. J Endocrinol 2011, 210:47-58.
32. Singh P.K., Brand R.E., Mehla K. MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol 2012, 9:334-344.